Clinical trials have demonstrated that both biosimilars match the reference product's quality, safety and efficacy standards.

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...

An expert panel finds no link between COVID-19 vaccines and heart attacks, attributing rising cases to lifestyle, genetics, ...

Karnataka CM Siddaramaiah and Biocon chief Kiran Mazumdar-Shaw have been up in arms against each other over the heated debate ...

BJP spokesperson Dr CN Ashwath Narayan criticised Siddaramaiah, alleging that his statement was aimed at discrediting ...

Biocon Ltd's arm, Biocon Biologics Ltd, has received European Commission authorisation for its Vevzuo and Evfraxy biosimilars ...

Biocon Biologics receives European Commission approval for Vevzuo and Evfraxy, biosimilars of Denosumab, used to treat ...

Evfraxy is authorised for the treatment of osteoporosis in men with prostate cancer as increased risk of fractures or ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...